Bayer Cropscience Financial Results
- Market cap
- ₹15,680 crore
- P/E
- 21.4
- P/B
- 5.29
- ROE
- 23.7%
- Dividend yield
- 1.72%
For the year ended Mar 2023, Bayer Cropscience reported revenue of ₹4,945 crore and net profit of ₹758 crore, against ₹4,892 crore and ₹740 crore a year earlier.
Bayer Cropscience annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | 4,945 | 4,892 | 5,314 | 5,498 | 5,595 |
| Expenses | 4,006 | 3,910 | 4,620 | 4,620 | 4,702 |
| Operating profit | 939 | 982 | 694 | 878 | 893 |
| Operating margin % | 19% | 20% | 13% | 16% | 16% |
| Other income | 153 | 52 | 115 | 91 | 165 |
| Interest | 22 | 20 | 17 | 20 | 19 |
| Depreciation | 80 | 74 | 85 | 94 | 117 |
| Profit before tax | 990 | 941 | 707 | 855 | 922 |
| Tax % | 23% | 21% | 20% | 19% | 21% |
| Net profit | 758 | 740 | 568 | 689 | 732 |
| EPS (₹) | 168.71 | 164.77 | 126.38 | 153.35 | 162.90 |
| Dividend payout % | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Bayer Cropscience financial results — frequently asked questions
What is Bayer Cropscience's annual revenue and net profit?
For the financial year ended Mar 2023, Bayer Cropscience's revenue was ₹4,945 crore and net profit ₹758 crore; net profit rose 2.43% from ₹740 crore in Mar 2024.
How fast has Bayer Cropscience grown over three years?
From Mar 2026 to Mar 2023, Bayer Cropscience's revenue grew at a compound annual rate of -3.5% and net profit at 3.2%. Past growth does not indicate future results.
What is the EPS of Bayer Cropscience?
Annual EPS for Mar 2023 was ₹168.71.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Bayer Cropscience With ATS
Track BAYERCROP live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.